Atomwise develops artificial intelligence systems using powerful deep learning algorithms and supercomputers for drug discovery.
Atomwise has raised $45.0M in total funding. The most recent round was Series C. The last funding was announced in January 2024.
Atomwise's investors include Y Combinator, Khosla Ventures, Bill & Melinda Gates Foundation, B Capital, Draper Associates.
Atomwise is headquartered in San Francisco, United States.
Atomwise develops artificial intelligence systems using powerful deep learning algorithms and supercomputers for drug discovery.
Atomwise is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Atomwise — Funding & Investors." VCBacked, January 1, 2024, https://www.vcbacked.co/company/atomwise. Accessed July 19, 2026.
VCBacked. (2024). Atomwise — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/atomwise
{{cite web |title=Atomwise — Funding & Investors |url=https://www.vcbacked.co/company/atomwise |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated